Navigation Links
Survival in metastatic breast cancer directly linked to circulating tumor cells
Date:5/6/2010

Brussels, 6 May 2010 -- A new study of metastatic breast cancer shows that the number of circulating tumor cells patients have in their blood directly correlates with the length of their survival. Reported at the IMPAKT Breast Cancer Conference in Brussels, Belgium, the results have the potential to improve the delivery of personalized therapy to these patients.

Circulating tumor cells --cancer cells found in a patient's bloodstream-- are detected in 50% to 80% of patients with metastatic breast cancer. Since 2004, doctors have known that patients with 5 or more of these cells in 7.5 ml of blood survive on average for less time than those with fewer than 5 cells.

Dr Antonio Giordano from MD Anderson Cancer Center in Houston, USA, and colleagues set out to refine this prognostic test using a sophisticated computer model known as an artificial neural network.

"We chose to use an artificial neural network model to analyze 516 consecutive metastatic breast cancer patients at the University of Texas MD Anderson Cancer Center because, unlike more typical statistical methods, it can estimate the complex interactions between different factors over time," said Dr Giordano. "Our model, designed at the University of Naples Federico II, simply represents a dynamic time-related analysis of survival, taking into account all prognostic factor correlations."

Using the artificial neural network, the researchers studied the relationship between increasing numbers of circulating tumor cells and survival for different subgroups of breast cancer.

"We found that there was a linear relationship between the number of circulating tumor cells and the risk of death in patients with metastatic breast cancer. Most importantly, the risk of death after 1 year for patients with 40 circulating tumor cells in 7.5 ml of blood was about twice that for patients with none."

"These results show that the simple cutoff number of 5 circulating tumor cells probably does not adequately represent the complexity of this prognostic variable," Dr Giordano said. "Artificial neural networks are sophisticated techniques for analyzing survival of patients according to continuous variables over time."

Translated to clinical practice, these results suggest that monitoring of circulating tumor cell numbers should now be considered a standard test for patients with metastatic breast cancer, Dr Giordano said.

"While the treatment of this condition remains palliative, monitoring of circulating tumor cells can help determine when to modify regimens or discontinue therapy, in other words, this can improve the delivery of personalized therapy."


'/>"/>

Contact: Vanessa Pavinato
media@esmo.org
European Society for Medical Oncology
Source:Eurekalert

Related medicine news :

1. One Sigmoidoscopy Boosts Colon Cancer Survival Odds
2. Youngest Preemies Survival Rate Unchanged
3. Researchers Boost Post-Heart Attack Survival in Mice
4. Beta-blockers help reduce metastasis and improve survival in breast cancer patients
5. Survival in metastatic breast cancer patients is improving: targeted therapies have contributed
6. Pregnancy for breast cancer survivors: Meta-analysis reveals it is safe and could improve survival
7. Accepting Help Improves Survival Among Diabetics
8. New therapies increase survival rates in post-transplant liver cancer patients
9. Chemo May Boost Survival After Lung Cancer Surgery
10. Recurrence of breast cancer after more than 10 years is an important indicator of survival
11. Mammograms May Not Boost Survival, Danish Study Suggests
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... ... , ... According to a new study by NCPA Senior Fellow John R. ... rules Congress has directed the CBO to follow. The CBO itself previously recognized Obamacare ... it estimates a reduction in employer-based coverage due to the GOP reform, which is ...
(Date:3/24/2017)... ... ... The iaedp Foundation, the premier provider of educational programs and training standards for eating ... of disordered eating, announced today that the 2017 Symposium set a new attendance record ... countries converged on the Green Valley Resort in Las Vegas. , “We are ...
(Date:3/24/2017)... ... March 24, 2017 , ... ... Premier Center for Shamanic Healing and Spiritual Awakening, proudly presents her Sacred ... 2017. This sacred and spiritual journey during the Summer Solstice will also ...
(Date:3/24/2017)... ... March 24, 2017 , ... As ... to create a communications platform that positions them as the go-to thought leader ... reinvented their online publication as an always-on, always-fresh news, views and advocacy engine, ...
(Date:3/24/2017)... ... March 24, 2017 , ... On June ... ERISA Benefit Claims Litigation seminar in Chicago, Illinois. She will present on: ... of cases litigated under ERISA involve claims for long-term disability benefits. This ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... 23, 2017  HealthMine surveys with 9,250 insured consumers ... health plan members want help from their plans in ... in their health, 2) help closing gaps in care, ... health and 5) relevant, real-time guidance. Meeting these needs ... costs. A Reason to Stay ...
(Date:3/24/2017)... , March 23, 2017  Provectus Biopharmaceuticals, ... the "Company"), a clinical-stage oncology and dermatology biopharmaceutical ... Definitive Financing Commitment Term Sheet (the "Definitive Financing") ... group of the Company,s stockholders, who are referred ... in a Form 8-K filed with the Securities ...
(Date:3/24/2017)... 24, 2017 The Board of Directors of ... Report 2016 including the complete 2016 Annual Accounts with notes. ... Nordic Nanovector,s website in the section Investor Relations/Reports and presentations/Annual ... ... Kvåle, Chief Financial Officer Cell: +47-91-51-95-76 Email: ir@nordicnanovector.com ...
Breaking Medicine Technology: